论文部分内容阅读
Objective The aim of this study was to evaluate the safety and efficacy of multi-kinase inhibitor plus endostar treatment in patients with metastatic renal cell carcinoma(mRCC)and pleural effusion.Methods A total of 10 patients with mRCC(8 clear-cell RCCs